Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;46(suppl.1):145-155.
doi: 10.1590/S1677-5538.IBJU.2020.S114.

Early experience with COVID-19 in kidney transplantation recipients: update and review

Javier González  1 , Gaetano Ciancio  2   3   4
Affiliations
Review

Early experience with COVID-19 in kidney transplantation recipients: update and review

Javier González et al. Int Braz J Urol. 2020 Jul.

Abstract

Introduction: little is known on the risk factors, clinical presentation, therapeutic protocols, and outcomes of kidney transplantation recipients (KTRs) who become infected by SARS-CoV-2.

Purpose: to provide an updated view regarding the early experience obtained from the management of KTRs with COVID-19.

Materials and methods: A narrative review was conducted using PubMed database to identify relevant articles written in English/Spanish, and published through May 15, 2020. Search terms included: "coronavirus", "severe acute respiratory syndrome coronavirus 2", "SARS-CoV-2", "COVID-19", "COVID", "renal transplantation", and "kidney transplantation". Case series were considered eligible, and case reports excluded. Thirty-four articles were included in the review.

Results: KTRs should be considered immunocompromised hosts: potential risk for infection, non-negligible comorbidity, and exposure to long-term immunosuppression. Only single center small retrospective experiences are still available regarding KTRs with COVID-19. SARS-CoV-2 symptoms in KTRs are similar to that observed for the general population, being fever and cough the most frequently observed. Mild-to-moderate symptomatic KTRs can be managed in an outpatient setting, while patients exhibiting severe symptoms must be addmited to hospital. More rapid clinical progression, and higher complication and death rates have been observed for hospitalized KTRs, requiring hemodyalisis or ventilatory support. Lymphopenia, elevated serum markers (C-reactive protein, procalcitonin, IL-6, D-dimer), and chest-X-ray findings consistent with pneumonia are linked to worse prognosis. A number of antiviral therapies have been used. However, it is difficult to draw meaningful conclusions regarding their efficacy at this point. Baseline immunosupression regimen should be adjusted in a case-by-case manner. However, it poses a significant challenge.

Keywords: COVID-19 [Supplementary Concept]; Immunosuppression; Kidney Transplantation.

PubMed Disclaimer

Conflict of interest statement

None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. [No Author]. Columbia University Kidney Transplant Program Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. J Am Soc Nephrol. 2020;31:1150–1156. - PMC - PubMed
    2. 1. [No Author]. Columbia University Kidney Transplant Program. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. J Am Soc Nephrol. 2020; 31:1150-6. - PMC - PubMed
    1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. Erratum in: Nature. 2020; 580:E7. - PMC - PubMed
    2. 2. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579:265-9. Erratum in: Nature. 2020; 580:E7. - PMC - PubMed
    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. - PMC - PubMed
    2. 3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395:565-74. - PMC - PubMed
    1. Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, et al. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med. 2020 ahead of print. - PMC - PubMed
    2. 4. Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, et al. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med. 2020. ahead of print. - PMC - PubMed
    1. Coronavirus Resource Center . Coronavirus COVID-19 global cases by the Center for Systems Science and Engenieering (CSSE) Johns Hopkins University; [No author] [Internet]. Available at. < https://coronavirus.jhu.edu/map.html>.
    2. 5. [No author] Coronavirus Resource Center. Coronavirus COVID-19 global cases by the Center for Systems Science and Engenieering (CSSE). Johns Hopkins University. [Internet]. Available at. <https://coronavirus.jhu.edu/map.html>.